Skip to content

Drug interactions

Bosentan + Lomitapide

Severity: Moderate

Bosentan and Lomitapide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lomitapide is metabolised by CYP3A4, so bosentan may reduce its exposure and weaken LDL-lowering effect. Both drugs can also cause liver enzyme elevations, adding to hepatic monitoring concerns.

What this interaction means in plain words

Bosentan and Lomitapide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Bosentan belongs to Miscellaneous; Lomitapide belongs to Cardiovascular.

Evidence level: Low

Why it happens

Bosentan induces CYP3A4, increasing lomitapide clearance.

What to do

Monitor LDL cholesterol response and liver enzymes, adjusting lomitapide dose as appropriate.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Bosentan and Lomitapide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Bosentan with Lomitapide?

MediHelp rates the interaction as moderate. Bosentan and Lomitapide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Lomitapide is metabolised by CYP3A4, so bosentan may reduce its exposure and weaken LDL-lowering effect. Both drugs can also cause liver enzyme elevations, adding to hepatic monitoring concerns.

How serious is the interaction between Bosentan and Lomitapide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor LDL cholesterol response and liver enzymes, adjusting lomitapide dose as appropriate.

What other medicines interact with Bosentan?

MediHelp also lists interactions of Bosentan with, for example, Cyclosporin, Glibenclamide, Glyburide-metformin. The full list is on the Bosentan page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in